SecBot SecBot
6-K ·Filed Oct 2, 2026

IMCC

IM Cannabis Corp.
MIXED
Impact 6/10
Horizonweeks Processed24d 7h ago SEC0001178913-26-004699
Notable filing: 6-K
Actionable Insight ◆ Mixed

Monitor the next quarterly filing for actual accounting impact of the sale and any changes in cash runway. The related-party nature and reliance on financial hardship exemptions suggest limited negotiating leverage — watch for any post-closing adjustments or litigation. The concurrent equity offering at a 52% discount to the prior closing price (US$2.00 vs US$4.14) adds near-term dilution pressure.

DirectionMixed
Confidencehigh
Horizonweeks
Latest settled — T+5d
IMCC ▼ -24.74% at T+5d
NEUTRAL call -24.74% · α vs SPY -25.16% · entry $1.94 → $1.46
Next anchor: T+20d in 3d
Latest observation: T+14 -43.65% FF3 residual α
Entry = T+0 close
Oct 2, 2026
via day close
T+1d
0.00%
call 0.00% · α -0.55%
$1.94
settled 22d ago
T+5d
-24.74%
call -24.74% · α -25.16%
$1.46
settled 18d ago
T+20d
Pending
in 3d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

IM Cannabis Corp. closed the sale of IMC Holdings and its European-focused operations to Slil.com Holding Ltd., a company controlled by CEO Oren Shuster, for a C$3,000,000 advance payment and assumption of up to C$9,400,000 in retained liabilities. The transaction is expected to improve shareholders' equity by approximately C$3 million and streamline the company's focus on Israeli medical cannabis operations. This follows a recent registered direct offering of 655,000 common shares at US$2.00 per share for gross proceeds of approximately US$1.3 million, closed on September 24, 2026.

Key Facts

  • Closed sale of IMC Holdings (European operations) to Slil.com Holding Ltd., controlled by CEO Oren Shuster, on September 29, 2026.
  • Consideration: C$3,000,000 advance payment previously made by Slil plus assumption of up to C$9,400,000 in retained liabilities.
  • Expected improvement of approximately C$3 million in shareholders' equity per management's unaudited pro forma analysis.
  • Transaction structured as a related-party transaction; company relied on financial hardship exemptions from formal valuation and minority approval requirements under MI 61-101.
  • Company now focuses on retained Israeli medical cannabis operations.
  • Concurrent capital raise: 655,000 common shares sold at US$2.00 per share in a registered direct offering closed September 24, 2026, for gross proceeds of approximately US$1.3 million.
  • No securities of the company or IMC Holdings were issued or exchanged as consideration in the transaction.

Financial Impact

Expected improvement of approximately C$3 million in shareholders' equity; C$3,000,000 advance payment received; up to C$9,400,000 in retained liabilities transferred; gross proceeds of US$1.3 million from concurrent equity offering.

shareholders' equityworking capitalliabilitiescorporate structure

Risk Factors

  • Related-party transaction with CEO creates potential conflicts of interest and may limit value realization.
  • Reliance on financial hardship exemptions indicates serious financial difficulty — going-concern risk remains.
  • Retained Israeli operations may not perform as expected; no financial projections provided.
  • Post-closing adjustments, indemnification obligations, or tax liabilities could reduce anticipated benefits.
  • Nasdaq continued listing compliance risk remains.

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001178913-26-004699
Document: zk2636170.htm0001178913-26-004699
Document: 0001178913-26-004699-index-headers.html0001178913-26-004699
Document: 0001178913-26-004699-index.html0001178913-26-004699
Document: 0001178913-26-004699.txt0001178913-26-004699
17 reports for IMCC
Performance horizon
100% Hit rate @ T+20 9 of 9 directional calls Went positive at some point 9 of 9 best @ T+60▲ +71.43%Jun 9, 2026
Filters
Rows
Reports for IMCC — sortable, filterable
TypeNow
Oct 21, 2026
6d ago
EFFECT
NEUTRAL ★ 4/10
$1.19awaiting T+20—$0.8700 (−26.89%)
Oct 2, 2026
24d ago
6-K
MIXED ★ 6/10
$1.94awaiting T+20—$0.8700 (−55.15%)
Sep 25, 2026
4w ago
6-K
BEARISH ★ 6/10
$2.48 $0.8400▲ +66.13%▲ +66.10%$0.8700 (+64.92%)
Sep 24, 2026
4w ago
424B5
BEARISH ★ 7/10
$3.18 $0.9250▲ +70.91%▲ +70.49%$0.8700 (+72.64%)
Sep 24, 2026
4w ago
6-K
BEARISH ★ 6/10
$3.18 $0.9250▲ +70.91%▲ +70.49%$0.8700 (+72.64%)
Sep 23, 2026
4w ago
6-K
MIXED ★ 6/10
$2.91 $1.19▼ −59.11%▼ −59.79%$0.8700 (−70.10%)
Aug 17, 2026
10w ago
6-K
MIXED ★ 6/10
$0.1050 $0.0543▼ −48.25%▼ −46.28%$0.8700 (+728.57%)
Aug 13, 2026
10w ago
Press Release
BEARISH ★ 7/10
$3.66 $1.72▲ +53.01%▲ +51.01%$0.8700 (+76.23%)
Aug 13, 2026
10w ago
6-K
BEARISH ★ 8/10
$3.66 $1.72▲ +53.01%▲ +51.01%$0.8700 (+76.23%)
Jul 27, 2026
13w ago
6-K
NEUTRAL ★ 2/10
$0.1088 $0.1088· 0.00%▼ −3.38%$0.8700 (+699.63%)
Showing 10 of 17

US Market Status

Market Closed — Opens in 8h 15m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 2, 2026